Brewing is closing after nearly eight years of business in Milwaukee and just two weeks after it closed its West Bend taproom ...

Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

Immuneering has reported 94% overall survival (OS) at six months in first-line pancreatic cancer, emboldening the biotech to ...

Urgent pancreatic cancer tests will be offered on the NHS for those who are most at risk. GPs taking part in the NHS pilot ...

IL-6 blockades with tocilizumab did not improve short-term survival in advanced pancreatic cancer but showed potential ...

Around half of people diagnosed with pancreatic cancer will have been diagnosed with diabetes recently, according to NHS ...

New trial data reveals atebimetinib combined with gemcitabine/nab-paclitaxel significantly improves survival rates in ...

A call has been made to the Welsh Government to speed up pancreatic cancer diagnoses. Plaid Cymru deputy Senedd leader, ...

GPs and their teams will look for people over 60 who may have signs of the cancer, such as a recent diagnosis of diabetes and ...

Inoviq has issued a lengthy response to the ASX's 'please explain' pertaining to the company's early-stage cancer work.